Cargando…
A drug repurposing strategy for overcoming human multiple myeloma resistance to standard-of-care treatment
Despite several approved therapeutic modalities, multiple myeloma (MM) remains an incurable blood malignancy and only a small fraction of patients achieves prolonged disease control. The common anti-MM treatment targets proteasome with specific inhibitors (PI). The resulting interference with protei...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8897388/ https://www.ncbi.nlm.nih.gov/pubmed/35246527 http://dx.doi.org/10.1038/s41419-022-04651-w |